ClinicalTrials.gg
RecruitingNCT07557875Updated Apr 30, 2026

Healing Efficacy of Diode Laser in Lingual Frenectomy

An interventional study of Lingual Frenectomy using 940nm Diode Laser and Lingual Frenectomy using High-frequency Electrosurgery in Ankyloglossia and Tongue-tie, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Recruiting at 2 sites in Vietnam. Open to participants aged 3 Years to 6 Years. Per ClinicalTrials.gov, last updated 2026-04-30.

Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Oct 2024, registered Apr 2026).
  • Started Oct 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
3 Years to 6 Years
Sex
All
01

Study summary

This study aims to compare the wound healing efficacy and postoperative experiences between the 940 nm diode laser technique and the traditional electrosurgery method for treating ankyloglossia (tongue-tie) in children aged 3 to 6 years.

Participants are randomly assigned to one of two groups: Experimental Group - Patients undergo lingual frenectomy using a 940 nm diode laser and Active Comparator Group - Patients undergo the procedure using conventional high-frequency electrosurgery.

The study evaluates several key outcomes at multiple intervals (24 hours, 3 days, 1 week, and 1 month post-surgery), including: (1) Wound Healing: Measured by the Early Wound Healing Score (EHS); (2) Pain Levels: Assessed using the Wong-Baker FACES Pain Rating Scale; (3) Bleeding Control: Evaluation of intraoperative bleeding; (4) Tongue Mobility: Measurement of free tongue length according to Kotlow's classification.

The goal is to determine if the diode laser provides superior healing, less pain, and better bleeding control compared to electrosurgery.

Read the detailed description

Participant Allocation: Participants meeting the inclusion criteria (aged 3-6, diagnosed with Kotlow grade 3 or 4 ankyloglossia) are randomly assigned to one of two groups using a simple randomization method (drawing lots):

  • Group 1 (Laser Group): Lingual frenectomy performed using a 940 nm Diode Laser (Epic X, Biolase) with a power of 1W (average) and 2W (peak) in pulsed mode (CP2).
  • Group 2 (Electrosurgery Group): Lingual frenectomy performed using a high-frequency electrosurgical unit (ERBE-VIO 100C) in continuous contact mode.

Surgical Procedure: Both groups follow a standardized surgical protocol:

  • Anesthesia: Local anesthesia with 2% Lidocaine/Adrenaline (0.45 ml).
  • Technique: Transverse incision without suturing or muscle dissection to release the lingual frenum.
  • Safety Measures: Use of protective eyewear for the laser group and electrode grounding pads for the electrosurgery group.

Data Collection and Blinding:

  • Blinding: This is a single-blind study where the participants and their guardians are unaware of the assigned treatment group. The evaluator measuring post-operative outcomes is also blinded to the surgical method used.
  • Follow-up Schedule: Evaluations are conducted at five specific intervals:

    • Baseline (T0): Pre-operative measurements.
    • Post-operative: At 24 hours (T1), 3 days (T2), 1 week (T3), and 1 month (T4).

Evaluation Criteria:

  • Wound Healing: Assessed by the Early Wound Healing Score (EHS), focusing on re-epithelialization (CSR), haemostasis (CSH), and inflammation (CSI).
  • Pain Intensity: Self-reported by patients using the Wong-Baker FACES Pain Rating Scale.
  • Tongue Function: Measuring the increase in free tongue length (mm) using a Quick Tongue-Tie (QTT) tool.
02

Conditions studied

  • Ankyloglossia
  • Tongue-tie

Keywords

  • Ankyloglossia
  • Tongue-tie
  • Lingual frenectomy
  • Diode laser
  • Electrosurgery
  • Wound healing
  • Postoperative pain
  • Early Wound Healing Score (EHS)
  • Wong-Baker FACES Pain Rating Scale
  • Kotlow's classification
03

In context

Ankyloglossia

32 studies on the registry are indexed under Ankyloglossia; 8 are open to participants now.

This study's planned enrollment of 53 is below the median of 105 across 22 interventional studies indexed under Ankyloglossia.

Browse Ankyloglossia studies →

Lead sponsor

University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 127 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged between 3 and 6 years.
  • Diagnosed with grade 3 or grade 4 ankyloglossia according to Kotlow's classification (1999).
  • Parents or legal guardians provide for the child to participate in the study.
  • Patients and guardians agree to follow the follow-up schedule (24 hours, 3 days, 1 week, and 1 month post-surgery).

Exclusion criteria

Exclusion Criteria:

  • History of allergy to local anesthetics (e.g., Lidocaine, Adrenaline).
  • Patients with systemic diseases or high-risk surgical factors (e.g., cardiovascular disease, bleeding disorders, hemophilia, epilepsy, or uncontrolled asthma).
  • Uncooperative patients who are unable to undergo the procedure under local anesthesia or fail to follow post-operative instructions.
  • Patients who withdraw from the study before completion.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
53 participants (estimated)

Study arms

  • Experimental
    Diode Laser Group

    Patients in this group undergo lingual frenectomy using a 940 nm diode laser (Epic X, Biolase). The procedure is performed using a transverse incision technique without suturing. Laser settings include an average power of 1W, peak power of 2W in pulsed mode (CP2), and a 940 nm wavelength.

    Procedure: Lingual Frenectomy using 940nm Diode Laser

  • Active comparator
    Electrosurgery Group

    Patients in this group undergo lingual frenectomy using a high-frequency electrosurgical unit (ERBE-VIO 100C). The procedure follows the same transverse incision protocol without suturing as the experimental group.

    Procedure: Lingual Frenectomy using High-frequency Electrosurgery

Interventions

  • ProcedureLingual Frenectomy using 940nm Diode Laser

    Lingual frenectomy performed using a 940 nm Diode Laser (Epic X, Biolase). The laser is set to pulsed mode (CP2), average power 1W, and peak power 2W. The procedure involves a transverse incision to release the frenum without suturing. Protective eyewear is mandatory for the patient and surgical team.

    Also known as: Diode Laser Frenectomy, Laser-assisted Frenotomy

  • ProcedureLingual Frenectomy using High-frequency Electrosurgery

    Lingual frenectomy performed using a high-frequency electrosurgical unit (ERBE-VIO 100C). The procedure follows a standardized transverse incision protocol without suturing. A grounding pad (electrode) is applied to the patient's body to complete the circuit. This serves as the active comparator representing the conventional surgical method at the hospital.

    Also known as: Electrosurgical Frenectomy, Electrocautery Frenotomy

06

What researchers measure

Primary outcomes

  1. Early Wound Healing Score (EHS)

    The EHS is used to evaluate the early healing of periodontal soft tissue wounds. It is the sum of three components: Clinical Signs of Re-epithelialization (CSR), Clinical Signs of Haemostasis (CSH), and Clinical Signs of Inflammation (CSI). The total score ranges from 0 to 10, where a higher score indicates better and faster wound healing (10 being perfect healing).

    Time frame: 24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.

Secondary outcomes

  1. Pain Intensity assessed by Wong-Baker FACES Pain Rating Scale

    Patients self-assess their pain levels using a scale of 6 faces representing different pain intensities. Scores range from 0 (no pain) to 10 (worst possible pain), with increments of 2 (0, 2, 4, 6, 8, 10).

    Time frame: 24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.

  2. Level of Intraoperative Bleeding

    Bleeding is assessed during the surgical procedure and categorized into 2 levels: Grade 1 (No bleeding) and Grade 2 (Bleeding present, requiring local haemostatic measures like gauze pressure or laser/electrosurgery coagulation).

    Time frame: During the surgical procedure (T0)

  3. Increase in Free Tongue Length

    Measured as the distance (in mm) from the attachment of the lingual frenum on the ventral surface of the tongue to the tip of the tongue using a Quick Tongue-Tie (QTT) measurement tool.

    Time frame: Baseline (T0), 1 week (T3), and 1 month (T4) post-surgery.

07

Study locations

2 of 2 sites recruiting
  • Children's Hospital 1, Department of Odonto-Stomatology
    Ho Chi Minh City, Vietnam
    Recruiting
    • Phung Van Ho, DDS · Contacthvphung.ckii.rhm23@ump.edu.vn · (+84) 983791484
    • Phung Van Ho, DDS · Principal investigator
    • Phong Dai Lam, PhD, DDS · Sub investigator
  • Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
    Ho Chi Minh City, Vietnam
    Recruiting
    • Phong Dai Lam, PhD, DDS · Contactphonglam@ump.edu.vn · (+84) 906312958
    • Phung Van Ho, DDS · Sub investigator
08

References and documents

Publications

  • Kotlow LA. Ankyloglossia (tongue-tie): a diagnostic and treatment quandary. Quintessence Int. 1999 Apr;30(4):259-62. PubMed 10635253 ↗
  • Hwang WB, Kim DJ, Oh GS, Park JH. Aryl Hydrocarbon Receptor Ligands Indoxyl 3-sulfate and Indole-3-carbinol Inhibit FMS-like Tyrosine Kinase 3 Ligand-induced Bone Marrow-derived plasmacytoid Dendritic Cell Differentiation. Immune Netw. 2018 Oct 23;18(5):e35. doi: 10.4110/in.2018.18.e35. eCollection 2018 Oct. PubMed 30402330 ↗
  • Mazzoni A, Navarro RS, Fernandes KPS, Mesquita-Ferrari RA, Horliana ACRT, Silva T, Santos EM, Sobral APT, Junior AB, Nammour S, Motta LJ, Bussadori SK. Comparison of the Effects of High-Power Diode Laser and Electrocautery for Lingual Frenectomy in Infants: A Blinded Randomized Controlled Clinical Trial. J Clin Med. 2022 Jun 30;11(13):3783. doi: 10.3390/jcm11133783. PubMed 35807068 ↗

Individual participant data

Plan to share: No — The individual participant data will not be shared to ensure absolute confidentiality for the pediatric patients and their families, as stated in the informed consent and study protocol approved by the Ethics Committee.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2024 (actual). Primary completion is estimated for Sep 2026, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 22, 2026
First posted
Apr 30, 2026
StartActual
Oct 1, 2024
Primary completionEst.
Sep 30, 2026
CompletionEst.
Oct 1, 2026
Last update
Apr 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07557875
Responsible party
Phong Dai Lam (Head of Department of Oral and Maxillofacial Radiology, Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City) — Principal investigator
First posted
Apr 30, 2026
Start date
Oct 1, 2024
Primary completion
Sep 30, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Apr 30, 2026

Study contacts

Phong Dai Lam, PhD, DDS
Contact
phonglam@ump.edu.vn
(+84) 906312958

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion